GALERA THERAPEUTICS INC (GRTX)
US36338D1081 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -59.08M | -62.22M | -80.53M | -74.22M | -51.93M | |||
| Depreciation Amortization | 259.00K | 110.00K | 780.00K | 370.00K | 270.00K | |||
| Income Taxes - Deferred | 0.00 | -70.00K | 0.00 | -20.00K | -10.00K | |||
| Change In Working Capital | -6.17M | 3.26M | -2.63M | 3.91M | -660.00K | |||
| Other non cash items | 20.14M | 15.49M | 14.43M | 10.42M | 5.67M | |||
| OPERATING CASH FLOW | -44.85M | -43.43M | -67.96M | -59.54M | -46.66M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -59.00K | -30.00K | -280.00K | -460.00K | -630.00K | |||
| Other Investing Activity | 27.35M | 24.02M | 5.52M | 37.00M | -27.19M | |||
| INVESTING CASH FLOW | 27.29M | 23.99M | 5.24M | 36.55M | -27.83M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 57.50M | 20.00M | 20.00M | |||
| Stock Issued/Repurchased | 29.49M | 3.89M | 9.21M | 510.00K | 58.03M | |||
| Other Financing Activity | 2.01M | N/A | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 31.50M | 3.89M | 66.71M | 20.51M | 78.03M | |||
| CHANGE IN CASH | 13.94M | -15.55M | 3.99M | -2.48M | 3.54M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -44.85M | -43.43M | -67.96M | -59.54M | -46.66M | |||
| Capital Expenditure | -59.00K | -30.00K | -280.00K | -460.00K | -630.00K | |||
| FREE CASH FLOW | -44.91M | -43.46M | -68.24M | -60.00M | -47.29M | |||
All data in USD